Sidley represented the joint placing agents CLSA Limited and Haitong International Securities Company Limited in the placing of 20.7 million new H shares under general mandate by InnoScience (Suzhou) Technology
Sidley represented the joint placing agents CLSA Limited and Haitong International Securities Company Limited in the placing of 20.7 million new H shares under general mandate by InnoScience (Suzhou) Technology
Sidley represented VoltaGrid LLC (VoltaGrid), a U.S.-based clean energy innovator, in its strategic collaboration with Oracle Corporation to deploy more than 2,300 megawatts (MW) of ultra-low-emissions power infrastructure to support
Linklaters has advised the banks on Verisure plc’s €13.7bn initial public offering and listing on Nasdaq Stockholm. This landmark listing for Verisure, the leading provider of professionally installed and monitored
Global law firm Clifford Chance has advised STEAG Power GmbH, a leading Germany-based energy company, on the sale of its 51% stake in İSKEN to OYAK, one of Türkiye’s foremost
Clifford Chance has advised Emirates Growth Fund Limited (EGF), the UAE’s flagship growth capital platform backed by Emirates Development Bank (EDB), on its inaugural investment: a strategic minority stake in
The international law firm Baker McKenzie has advised Return on entering a partnership with BESSMART Energies GmbH. As part of the collaboration, Return is acquiring four battery storage sites in
Baker McKenzie represented Takeda in its global strategic collaboration with Innovent Biologics, bolstering Takeda’s oncology pipeline with next-generation investigational medicines for the treatment of solid tumors. Under terms of the
Baker McKenzie represented Takeda in its global strategic partnership with Innovent Biologics, bolstering Takeda’s oncology pipeline with next-generation investigational medicines for the treatment of solid tumors. Under terms of the
Boston Scientific Corporation (NYSE: BSX) announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative
Rayonier (NYSE: RYN) and PotlatchDeltic (Nasdaq: PCH) announced they have entered into a definitive agreement to combine in an all-stock merger of equals, creating a leading domestic land resources owner